Recent metagenome

Recent metagenome selleck products studies of the gut microbiomes of the wood degrading higher termites, the Australian Tammar wallaby and two studies of the cow rumen metagenome have revealed new insights into the mechanisms of cellulose degradation in uncul tured organisms and microbial communities. Microbial communities of different herbivores have been shown to be dominated by lineages affiliated to the Bacteroidetes and Firmicutes, of which different Bacteroidetes lineages exhibited endoglucanse activity. Notably, exo acting families and cellulosomal structures have a low rep resentation or are entirely absent from gut metagenomes sequenced to date. Thus, current knowledge about genes and pathways involved in plant biomass degradation in different species, particularly uncultured microbial ones, is still incomplete.

We describe a method for the de novo discovery of protein domains and CAZy families associated with mi crobial plant biomass degradation from genome and metagenome sequences. It uses protein domain and gene family annotations as input and identifies those domains or gene families, which in concert are most distinctive for the lignocellulose degraders. Among the gene and protein domains identified with our method were known key genes of plant biomass degradation. Additionally, it identified several novel protein domains and gene fam ilies as being relevant for the process. These might rep resent novel leads towards elucidating the mechanisms of plant biomass degradation for the currently less well understood microbial species.

Our method furthermore can be used to identify plant biomass degrading species from the genomes of cultured or uncultured microbes. Application to draft genomes assembled from the metagenome of a switchgrass adherent microbial com munity in cow rumen predicted genomes from several Bacteroidales lineages which encode active glycoside hydrolases and a AV-951 relative to a known plant biomass de grader to represent lignocellulose degraders. In technical terms, our method selects the most infor mative features from an ensemble of L1 regularized L2 loss linear Support Vector Machine classifiers, trained to distinguish genomes of cellulose degrading species from non degrading species based on protein family content. Protein domain annotations are available in public databases and new protein sequences can be rapidly annotated with Hidden Markov Models or somewhat slower with BLAST searches of one pro tein versus the NCBI nr database.

Co occurrence of protein families in the biomass degrading fraction of samples and an absence of these families within selleck compound the non degrading fraction allows the classifier to link these proteins to biomass degradation without requiring sequence homology to known proteins involved in lignocellulose degradation. Classification with SVMs has been previously used successfully for phenotype predic tion from genetic variations in genomic data.

The tyrosine kinase inhibitor imatinib became the first line ther

The tyrosine kinase inhibitor imatinib became the first line therapy in the conventional treatment of CML, with a rela tively selective targeting of the ATP binding site of Bcr/Abl. However, selleck chemicals llc the emergence of resistance to imatinib remains a major problem especially for those patients with advanced CML, or with Ph positive ALL. This is due to point mutations in the Bcr/Abl kinase domain, including the most frequent T315I and E225K mutations. Sec ond generation tyrosine kinase inhibitors, such as nilotinib, dasatinib and bosutinib are capable of targeting the major ity of imatinib resistant mutations, but none of them are ef fective against leukemia cells harboring the T315I mutation. Thus, the need to find a more effective treatment for leukemia patients with this mutation is obvious.

Aurora kinases are key regulators of cell division and deregulation of this activity can result in aneuploidy and carcinogenesis. Therefore, they are attractive tar gets for anticancer therapy. Several small molecule inhibitors of Aurora kinases with various properties are in clinical trials including PHA 739358 , MLN8054 and AZD1152. PHA 739358 is a pan Aurora kinases inhibitor with activity against all Aurora kinase family members. Interestingly, and of importance for the potential use of this compound against poor prognosis ALL, Gontarewicz et al, using Bcr/ Abl constructs transfected into the BaF3 cell line, showed that PHA 739358 is also effective against imatinib resistant Bcr/Abl mutants including the T315I.

A determination of the crystal structure of the T315I Abl kinase domain in complex with PHA 739358 showed that the drug interacts with the active conformation of Abl kinase. Currently, preliminary evidence for anti tumor activity of PHA 739358 has been seen in various advanced refractory can cers, and phase II studies in solid tumors are ongoing. In this report, we performed GSK-3 preclinical studies in the presence of stroma in vitro as well as in vivo, to explore the application of PHA 739358 for treatment of a variety of primary human acute lymphoblastic leukemia cells including those belonging to the Ph positive ALL sub class and harboring the T315I mutation. We conclude that PHA 739358 could be considered Imatinib Mesylate mw for the treatment of patients with different subtypes of ALL in combin ation with other drugs to potentiate its cytostatic and cytotoxic effects. Results PHA 739358 reduces viability of acute lymphoblastic leukemia cells including those with the Bcr/Abl T315I mutation To determine the impact of the Bcr/Abl status on the effi cacy of PHA 739358, we treated human ALL cells includ ing BLQ1, Pt2, UCSF02, TXL2, US7, US7R and mouse 8093 and Bin2 cells with increasing concentrations of PHA 739358 for 72 hours.

Subsequently, we e amined whether PMA modulated the cell surface

Subsequently, we e amined whether PMA modulated the cell surface e pression of CCR1 and CCR2 by FACS anal ysis. THP 1 cells were again stimulated with PMA for the times indicated, before being stained with the appropriate antibodies and then analyzed by flow cytom etry. Whereas the levels of CCR1 remained high throughout the duration of the e periment, CCR2 protein e pression decreased dramatically. The majority of the e pression was lost by 24 hours and by 48 hours vir tually no CCR2 was found on the surface of the cultured THP 1 cells. Thus, THP 1 cells treated with PMA mimics the differentiation process observed in cultured monocytes. Two distinct signal transduction pathways regulate CCR2 e pression during monocyte maturation Our initial observations suggested that while PMA completely abrogated CCR2 e pression, sub optimal concentrations of this phorbol ester had no effect.

We wondered, therefore, whether the addi tion of a calcium signal together with the sub optimal concentration of PMA might provide a sufficiently strong stimulus to affect the e pression of CCR2. Thus, we incubated monocytes with PMA and ionomycin at the concentrations indicated for 48 hours, and then analyzed CCR2 e pression. Our data indicated that ionomycin alone does not affect e pression of CCR2. However, in the presence of a sub optimal PMA signal, there was a selective dose dependent reduction in CCR2 e pres sion. At the same time, similar concentrations of PMA and ionomycin did not affect the levels of CCR1 nor GAPDH.

Monocytes treated with PMA plus ionomycin were also observed to adopt an adherent phenotype and to increase in size similar to the changes in morphology observed in freshly isolated monocytes. Furthermore, cell surface e pression of CCR2, but not CCR1, was found to be downregulated in the presence of PMA plus iono mycin after 48 hours. Thus, sub opti mal concentrations of PMA together with a modest calcium signal combine to mediate a maturation pheno type in monocytes that also includes the selective down regulation of CCR2. To determine whether the selective downregulation of CCR2 observed in PMA versus PMA plus ionomycin treated cells represented the same or two different signal ing pathways, we performed an e periment using the broad spectrum kinase inhibitor, staurosporine.

We preincubated THP 1 cells with staurosporine at the concentrations indicated for two hours, and then stimu lated with either PMA or PMA plus ionomycin for 48 hours. Stau rosporine alone did not significantly inhibit e pression of CCR2 nor CCR1. Furthermore, the Batimastat inhibitor did not abrogate the downregulation of CCR2 mediated by PMA plus ionomycin. In contrast, staurosporine at 50 nM, but not at 10 nM, blocked the loss of CCR2 in PMA treated cells. Thus, these results identify at least two possible signal transduction pathways present in monocytes that could regulate the e pression of CCR2 during monocyte differ entiation.

Treatment with V wt vaccinated mice Igs was not effective on cell

Treatment with V wt vaccinated mice Igs was not effective on cell proliferation. Trastuzumab, a monoclonal antibodies to p185, was shown to induce down regulation of p185 receptor on cell membrane, to block its function by hampering the formation of homodimers and heterodimers and ligand binding. The ability of purified Igs from vaccinated mice to induce down regulation of p185 Neu was inves tigated by immunofluorescence and deconvolution ana lysis of immunolabeled SALTO cells. SALTO cells were stained with rV neuT purified Igs, then with a goat anti mouse fluorescent antibody and incubated for 1 hour at 37 C in a CO2 incubator in complete medium. As shown in Figure 4, Panel C, Igs from rV neuT vaccinated mice were able to induce down regulation of the p185 Neu re ceptor e pressed on the cell surface of SALTO cells.

MAP kinases, ERK1 and ERK2, are activated by ErbB2 Neu receptor and trans duce proliferation signals. Given that chronic treatment with 108 pfu rV neuT Igs was able to specifically inhibit SALTO cell growth, we investigated whether phosphor ylation of ERK1 ERK2 in SALTO cells was affected by rV neuT Igs treatment. V wt purified Igs were used as control. The amount of phosphorylated ERK1 and ERK2 proteins were compared to total ERK proteins. The level of total ERK1 2 did not change after 108 pfu rV neuT or V wt purified Igs treatment. Conversely, phosphorylation of ERK1 was significantly inhibited by 108 pfu rV neuT Igs as compared to V wt Igs treatment. pERK2 was only slightly inhibited.

To determine whether anti Neu Igs were able to trig ger apoptosis, SALTO cells were labeled with anti T cell immune response induced by rV neuT vaccination Splenocytes isolated from mice vaccinated with rV neuT or V wt after the final boost, were e amined for their abil ity to proliferate under various Neu peptides. Release of IL 2 and IFN AV-951 was measured in the supernatant to assess T cell immunoreactivity with specific Neu epitopes. Re sults are reported in Table 4. All analyzed Neu peptides, e cept for an unrelated gag peptide, were able to specific ally activate splenocytes from rV neuT immunized BALB neuT mice. ConA was used as positive control. However, the e tent of IL 2 and IFN release was dependent on the stimulating Neu peptide. The strongest IL 2 release was observed upon stimulation with r41 and r98 peptides which are located in the e tracellular domain of rat Neu sequence.

Lower IL 2 release was observed upon stimulation with r166 and r156 peptides located in the transmembrane and e tracellular domains, respectively, or with r15. 3 and r141 peptides. These latter are located in the e tracellular domain. The strongest IFN release was de tected upon stimulation with r166 and r141 peptides. High levels of IFN were also obtained upon r15. 3 and r98 pep tides.

NME4 suppressed the effects of miR 196 on cell migration and inv

NME4 suppressed the effects of miR 196 on cell migration and invasion To investigate whether the enhancement of cell migra tion and invasion by miR 196 occurred via the suppres sion of NME4, these cellular effects were analyzed upon e ogenous e pression of NME4 in miR 196 over e pressing cells. After verifying the e pression status of miR 196 and NME4 upon specific plasmid transfection, cell invasion and migration were e amined. MiR 196 transfection significantly pro moted cell invasion and migration. However, cell invasion and migration were inhibited by 39 and 43%, respectively, upon e ogenous NME4 e pression. Transfection of NME4 alone had no effect on cell invasion or migration. Hence, the effect of miR 196 on cell migration and inva sion is NME4 dependent.

Cellular function of miR 196 occurs through the NME4 JNK TIMP1 MMP1 9 molecular pathway The mitogen activated protein kinase pathway has been well characterized and demonstrated to play an important role in cell mobility. We investigated whether the effect of the miR 196 NME4 a is on cellu lar functions was regulated by MAPK molecules. Pos sible alterations in the phosphorylation status on three MAPK molecules, JNK, Erk, and p38, were e amined by immunoblotting upon the modulation of miR 196 or NME4 e pression via plasmid transfection. As shown in Figure 4A, miR 196 and NME4 had minimal effects on phospho Erk and phospho p38 levels. However, phospho JNK levels were significantly increased by 2. 6 and 1. 8 fold by miR 196a and miR 196b modulation, respectively, whereas p JNK levels were reduced to 0.

7 fold of control levels by NME4 modulation. These results suggest that the miR 196 NME4 a is stimulates JNK phosphorylation. The MMP family of proteins and their tissue inhibitor TIMP1, which can pro mote or inhibit the digestion of the e tracellular matri were also e amined. Consistently, e ogenous e pression of miR 196a or miR 196b suppressed TIMP1 e pression and enhanced MMP1 and MMP9 e pression. Consistently, e ogenous NME4 elevated TIMP1 e pression but suppressed MMP1 and MMP9 e pression. These results suggest that miR 196 promotes cell invasion through the NME4 JNK pathway, leading to the suppres sion of TIMP1 activity and elevation of MMP1 9 activity. To determine whether JNK phosphorylation affects MMP e pression, the JNK inhibitor SP600125 was used.

As shown in Additional file 2 Figure S5, the treatment with SP600125 suppressed phospho c Jun e pression with a concomitant increase in TIMP1 e pression and decrease in MMP1 9 e pression. These concentration dependent alterations Cilengitide suggest that TIMP1 and MMP1 9 are downstream targets of p JNK and p c Jun. To validate the regulation of the miR 196 NME4 pJNK TIMP MMP pathway, immunofluorescence staining and confocal microscopy were performed. As shown in Figure 4B, e ogenous miR 196 reduced NME4 e pression and elevated p JNK and MMP9 e pression compared to the findings in the control.

1B pro tein levels These findings suggest that the interaction o

1B pro tein levels. These findings suggest that the interaction of the tumor suppressor DAL 1 4. 1B and protein methyla tion pathway components is biologically important in controlling tumorigenesis. Results DAL 1 4. 1B induces apoptosis in MCF 7 cells via a caspase 8 dependent pathway Previous work from this laboratory identified DAL 1 4. 1B protein as a growth suppressor and apoptosis inducing protein in MCF 7 cells, which themselves do not e press endogenous DAL 1 4. 1B. In agreement with this find Induction DAL 1 4. 1B e pression in MCF7 Cl27 cells growth suppression. Hypothesizing that the unique binding partners for DAL 1 4. 1B may help elucidate its mechanism of action as a negative growth regulator, yeast two hybrid analysis was performed using the 336 residues of DAL 1 4.

1B FERM domain and a fetal lung cDNA library. Several strongly associating proteins, including 14 3 3 protein isoforms and and protein arginine N methyltransferase 3 were iden tified. PRMT3 and its family members post translationally form asymmetric NG, NG or symmetric w NG, NG dimethylarginine residues on proteins. This pro tein modification has been shown to regulate transduc tion of signals to the nucleus, transcription regulation through nuclear receptors, and RNA transport between the nucleus and cytoplasm ing, DAL 1 4. 1B inducible MCF 7 Cl27 cells underwent apoptosis when treated with 2 M Muristerone A for 48 hours to induce DAL 1 4. 1B e pression. The presence of DAL 1 4. 1B protein was confirmed by both Western blot analysis and flow cytometry. TUNEL analysis revealed that 48 hours of DAL 1 4.

1B protein e pression induced apoptosis. Not all cells in the MCF 7 Cl27 clone e press robust levels of DAL 1 4. 1B protein, even after repeated subcloning. Therefore we also analyzed the sub population of cells that showed high levels of DAL 1 4. 1B protein. In that analysis, apoptosis levels reached appro imately 80%. To better understand the apoptotic mechanisms invoked in MCF 7 cells upon e pression of DAL 1 4. 1B, global as well as specific caspase activation was e amined. FAM VAD FMK, a potent inhibitor of caspase activity that irre versibly binds to the reactive cysteine residue of the large subunit of caspases 1 9, was incubated with MCF 7 Cl27 cells with or without induction of DAL 1 4. 1B protein e pression to assess global caspase activation.

These probes utilize carbo yfluorescein labeled peptide fluoromethyl ketone caspase inhibitors and allow the fluorescent detection of active caspases in GSK-3 living cell systems. As shown in Figure 2A, the presence of DAL 1 4. 1B protein increased global caspase activation levels by 2. 5 fold suggesting that DAL 1 4. 1B induced apoptosis proceeds through a caspase dependent pathway. Three main effector caspases, caspases 3, 6 and 7, are thought to be directly involved in the e ecution of cas pase dependent apoptosis.

We quantified the proportion of apoptotic cells in ectopic caveol

We quantified the proportion of apoptotic cells in ectopic caveolin 1 or EGFP e pressing cells by counting the number of cells e hibiting nuclear conden sations per 100 e ogenous caveolin 1 or EGFP e pressing cells, stained with Hoechst 33342. Significant numbers of caveolin 1 e pressing cells e hibited apoptosis after trans fection, whereas only pases plays a role in caveolin 1 induced GH3 cell apopto sis, at least in part through caspase 8 signaling. Bromocriptine sensitizes the caveolin 1 induced apoptosis in GH3 cells Bromocriptine induces activation of p38 MAP kinase in GH3 cells. Activation of the p38 MAP kinase signal ing pathway in NIH3T3 cells causes phosphorylation of caveolin 1 on Tyr14. We e amined if there was any relationship between bromocriptine and caveolin 1 that affected GH3 cell apoptosis.

GH3 cells were allowed to transiently e press caveolin 1 for 24 hours, then 30 M bromocriptine was added for another 12 hours. The pro portion of apoptotic cells was determined by estimating the number of cells containing condensed nuclear DNA. After 12 hours of bromocriptine treatment, the number of apoptotic cells was 38% of the total caveolin 1 e pressing cell population compared to 24% without bromocriptine. Only 14% and 6% of the total cell population underwent apoptosis when cells were treated with bro mocriptine or vehicle for 12 hours. The data indicate that there is an interaction between caveolin 1 and bromocriptine in the induction of GH3 apoptosis.

Bromocriptine enhances phosphorylation of caveolin 1 Tyr14 Tyrosine14 phosphorylation of caveolin 1 was found to be associated with apoptosis in the human promyelocytic leukemia cell line HL 60 after etoposide induction, indicating phosphorylation of caveolin 1 tyrosine may play a role in apoptosis. To e plore whether bromocrip tine could induce caveolin 1 phosphorylation, GH3 cells were transfected with pcDNA4 caveolin 1 for 24 hours, then e posed to bromocriptine as indicated in figure 5B. Total proteins were e tracted, separated using SDS PAGE and e amined by Western blotting using an antibody spe cific for caveolin 1 phosphorylated at Tyr14. After 12 hours of bromocriptine treatment the Brefeldin_A amount of caveolin 1 phosphorylation was 3. 75 times higher than with vehicle treatment. Cellular protein from H2O2 e posed NIH3T3 cells was used as a positive control for phosphorylated caveolin 1. These data demonstrated that bromocriptine enhanced phosphorylation of caveo lin 1 in GH3 cells. Discussion In the present study, we demonstrated GH3 cells overe pressing caveolin 1 underwent apoptosis. Caveolin 1 has previously been reported to be associated with enhance ment of apoptotic sensitivity.

3 Hz/g and a resolution of 167 8 ��g [16] The micromechanical si

3 Hz/g and a resolution of 167.8 ��g [16]. The micromechanical silicon resonant accelerometer prototype developed by Chongqing University in 2010 has a sensitivity of approximately 55.03 Hz/g and a resolution of approximately 182 ��g [17]. Nanjing University of Science and Technology studied the temperature influence mechanism of the micromechanical silicon resonant accelerometer. An improved structure restraining thermal stress and a temperature compensation measure based on electrostatic stiffness was proposed. After the accelerometer is electrically pre-heated for 10 min, the bias stability of the prototype is 100 ��g, and the bias repeatability is 286 ��g. The scale factor stability is 51 ppm, and the scale factor repeatability is 2.7335 �� 10?3. The temperature coefficient of the resonator is 42 Hz/��C [18].

The China Academy of Aerospace Electronics Technology launched a micromechanical silicon resonant accelerometer prototype in 2013 with an unloaded resonant frequency of approximately 17 kHz and a scale factor of approximately 220 Hz/g. In the range of ?40�C+70 ��C, the temperature coefficient of the resonant frequency is ?71.5 �� 10?6/��C. The bias stability approaches 42.5 ��g within 1.5 h [19].The domestic SOG technique is currently adopted by most research institutions for fabricating micromechanical silicon resonant accelerometers. In this technique, the anodic bonding process is used to form a tight silicon-oxygen bond to adhere the silicon wafer and the glass wafer together.

Because of the mismatching thermal expansion coefficients of silicon and glass, thermal stress will be produced during the fabrication, packaging and use of the accelerometer. This thermal stress will seriously affect the accelerometer performance. In this study, the structure of the micromechanical silicon resonant accelerometer is optimized to reduce the temperature influence on the accelerometer. Thus, the closed-loop drive circuit is designed based on the phase-locked loop. A performance test is also performed on the developed prototype.2.?Structural Design of Micromechanical Silicon Resonant Entinostat AccelerometerA structural diagram of the micromechanical silicon resonant accelerometer is shown in Figure 1. The accelerometer is designed with a perfectly symmetrical differential structure.Figure 1.Structural diagram of the micromechanical silicon resonant accelerometer.Two identical double-ended tuning forks (DETFs) serve as the stress-sensitive resonators. The two DETFs are symmetrically arranged and connected by the proof mass, which converts the acceleration into an inertial force, which is later magnified by leverage before being transmitted to the resonators.

Helimote [6] is an energy harvesting system with a single storage

Helimote [6] is an energy harvesting system with a single storage for buffering solar energy Built on a Mica2 mote, Helimote recharges two AA Ni-MH batteries, and it can learn its energy availability and usage via an energy-monitoring component. Jiang et al. [7] designed Prometheus, a hybrid energy storage system for solar energy. Based on Telos mote, Prometheus can be powered by the supercapacitors, called the primary energy buffer, or by the rechargeable Li-ion battery, called the secondary energy buffer. If the primary buffer energy is less than some threshold, the mote falls back to the secondary buffer until the primary one recharges fully again. Similar to Prometheus, AmbiMax [8] uses the hybrid energy storage. However, AmbiMax tracks the maximum power point automatically, without the control of MCU.

Like our system, EverLast [9] is a supercapacitor-driven sensor mote and does not use any battery. EverLast uses a PFM (Pulse Frequency Modulation) controller and a PFM regulator to harvest the solar energy. To track the maximum power point, EverLast integrates a complex charging circuit. Besides outdoor solar energy, vibration, indoor light, thermal and wind energy sources have been studied to drive sensor motes [10,11]. The work in [12] gives a survey abo
Visual inspection has traditionally played a critical role in quality management of the construction process and damage detection in structures subjected to various loadings [1,2]. However, because structures have become increasingly complex (e.g.

, high-rise and irregular designs), visual inspections are becoming increasingly time consuming and labor intensive and suffer from expensive and subjective evaluations; these aspects represent critical problems in the application of this method to real structures. Because visual inspection is restricted to post-event assessments, immediate damage detection and safety evaluations of structures are nearly impossible.For Cilengitide these reasons, structural health monitoring (SHM) based on sensor technology has received considerable attention and has successfully replaced traditional visual inspection [3�C6]. The SHM of buildings, which is based on a wired sensor network, was initially conducted for simple civil structures. The development of monitoring systems enabled a real-time response evaluation of a structure.

However, the high installation cost of the cable that connects the sensor to the server and maintenance and management challenges remain unresolved issues.For these reasons, Straser [7] attempted to solve the problems of existing wire-based monitoring systems by proving the effectiveness of the wireless sensor network (WSN) in an actual building. The WSN system (WSNS) significantly decreased the installation cost of a wired sensor network, and thus, the high-nodal density of sensor networsks was realized, which enabled local damage detection.

The key point of the global appearance approach is the descripti

The key point of the global appearance approach is the description algorithm. Several alternatives can be found in the literature on this topic. Some authors make use of the Principal Components Analysis (PCA) to create visual models with mobile robots ([7,8]). This approach considers images as multidimensional data that can be projected in a new space with a lower dimensionality, retaining most of the information. Other authors make use of the Discrete Fourier Transform (DFT) to extract the most relevant information from the scenes. When working with panoramic images, we can use both the 2D DFT [9] or the Fourier Signature (FS), defined in [10]. The resulting descriptor is able to concentrate most of the information in a lower number of components.

Comparing to the classical PCA approaches, the DFT descriptors are invariant against rotations on the ground plane, their computational cost is relatively low and each scene descriptor can be computed independently on the rest of images. Finally, other authors have described the scenes based on the gradient magnitude or orientation. As an example, Kosecka et al. [11] make use of a gradient histogram to create a topological map and localize the robot.We have not found in the related literature any work which makes a deep comparison between global description techniques. In this work we have selected several of the most relevant techniques. We have adapted some of them to describe panoramic scenes. We have also tested their performance depending on their main parameters and we have made a comparative evaluation among them.

This comparison has been carried out from sever
Respiratory rate monitoring plays an important role in the control and follow-up of highly prevalent diseases, such as COPD [1] or sleep apnea [2,3]. With this aim, respiratory rate detection becomes a frequently-used alternative, also used with other physiological variables, such as, pulse oximetry and heart rate [4,5].Next, analysis of the main detection techniques��particularly those used in apnea��are completed, but its conclusions can be extended to the diagnosis of other respiratory pathologies. Polysomnography is the standard diagnosis technique for apnea [6,7]. However, it involves a long and laborious procedure demanding the presence of qualified healthcare staff, it is costly and also unpleasant for patients.

Respiratory polygraphy is another alternative Dacomitinib technique, which involves reduced complexity, low waiting time and little monetary cost, but it is an invasive technique.The fact that they are obstructive systems from the patient’s viewpoint, together with the complexity involved by their use, has led to the research into new monitoring systems, such as the so-called smart beds by means of pressure sensors [8]. However, due to the nature of this method, respiratory measurements can be affected by the patient’s weight and position.